Off-label use of sodium cantharidinate and vitamin B6 injection in cancer: a protocol for a systematic review and meta-analysis

Off-label use of sodium cantharidinate and vitamin B6 injection in cancer: a protocol for a systematic review and meta-analysis

Abstract Background In China, sodium cantharidinate/vitamin B6 (SC/VB6) injection has been approved since 2002 for the treatment of lung cancer and primary liver cancer. In addition to these authorized indications, clinical application of SC/VB6 is also common in various other types of cancer. Howev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wenzhen Jin, Yibin Zhang, Shu Pang, Dongdong Yao, Yiwen Huang
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	Systematic Reviews
Subjects:	Off-label use Sodium cantharidinate/vitamin B6 Cancer Systematic review Meta-analysis
Online Access:	https://doi.org/10.1186/s13643-025-02826-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigation of Abundance and Diversity of Cantharidin Compounds in the Hycleus colligatus, Mylabris schrenki, Mylabris cincta, and Hycleus schah Species from Kerman Province, Iran
by: Sara sadat Nezhad-ghaderi, et al.
Published: (2024-09-01)

Comparative effects of cantharidin and endothall on gene expression and activity of antioxidant enzymes in Cichorium intybus L.
by: Yalda GHOTBZADEH KERMANI, et al.
Published: (2020-09-01)

DDIT4/mTOR signaling pathway mediates cantharidin-induced hepatotoxicity and cellular damage
by: Wenchao Tang, et al.
Published: (2024-11-01)

The peculiarities of off-label use of drugs in pediatrics
by: S. M. Drohovoz, et al.
Published: (2020-10-01)

Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications
by: Muhammad Hafeez, et al.
Published: (2020-05-01)

Disorder of phospholipid metabolism in the renal cortex and medulla contributes to acute tubular necrosis in mice after cantharidin exposure using integrative lipidomics and spatial metabolomics
by: Tianmu He, et al.
Published: (2025-07-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

The prevalence and consequences of support for off-label Ozempic prescriptions
by: Timothy Callaghan, et al.

Off-label use of psychotropic drugs in youth
by: Haakon Gravanti Rosland, et al.
Published: (2025-07-01)

Legal Responsibility of Doctor Regarding off-label Drug Applications
by: Erdal Yüzbaşıoğlu
Published: (2012-03-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
by: S. R. Gilyarevskiy
Published: (2020-05-01)

Legal and Medical Aspects of Off-Label Medication Use. Point of View
by: O. V. Tsygankova, et al.
Published: (2019-03-01)

Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use
by: Xuelian TANG, et al.
Published: (2025-02-01)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data
by: Narin Akıcı, et al.
Published: (2020-12-01)

Assessment of mandatory declaration excipients in pediatric off label prescriptions in Spain
by: Irene Lizano-Díez, et al.
Published: (2025-07-01)

OFF-LABEL PRESCRIBING. POSSIBLE CAUSES, TYPES AND CONSEQUENCES. LEGAL REGULATION IN THE RUSSIAN FEDERATION
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)

Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review
by: Benyu Yang, et al.
Published: (2024-11-01)

Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review
by: Vítor Silva, et al.
Published: (2024-11-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

“Off-label” drugs: legal problems and socio-economic aspects of application practice
by: S. V. Russkikh, et al.
Published: (2023-08-01)

The Effectiveness of Topical Treatment for Plantar Warts: A Retrospective Cohort Study
by: Ana Mª Rayo Pérez, et al.
Published: (2024-11-01)

Case Report: White–Sutton syndrome and cannabidiol, an update on a reported patient with a successful response to off--label therapy
by: Lorenzo Perilli, et al.
Published: (2025-02-01)

Prescribing Patterns and Off-Label Use of Gabapentinoid Agents at Dhulikhel Hospital, Nepal: A Cross-Sectional Study
by: Adhikari S, et al.
Published: (2024-12-01)

Off-label therapeutic potential of topical roflumilast in dermatology: A narrative reviewCapsule Summary
by: Michelle E. Sowa, BSc, et al.
Published: (2025-12-01)

Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery
by: Zichao Ji, et al.
Published: (2025-05-01)

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Off-label: The results of adjunctive bone morphogenetic protein for challenging femur fractures; a review of two cases
by: Julia Anne Prodoehl, et al.
Published: (2024-04-01)

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
by: E. Cioli, et al.
Published: (2025-03-01)

Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Clinical, microbiological, and laboratory predictors of on- and off-label dalbavancin treatment failure
by: Maria Mazzitelli, et al.
Published: (2025-06-01)

Effects of Sodium Cantharidinate on Proliferation and Apoptosis of Gastric Cancer Cells by Inhibiting JAK2/STAT3 Pathway
by: Xinghong LIU, et al.
Published: (2024-11-01)

Off-label use of recombinant factor VIIa for neonatal pulmonary hemorrhage; a single-center experience
by: Özge Serçe Pehlevan, et al.
Published: (2025-07-01)

Current issues related to the off-label use of drugs and their potential solutions
by: K. S. Radaeva, et al.
Published: (2024-04-01)

Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists
by: Kateri J. Spinelli, et al.
Published: (2025-06-01)

Off-label drug use in China after the Physician Law (2021): legal challenges and solutions
by: Shenbao Liang, et al.
Published: (2025-04-01)

The cut-off values of vitamin D deficiency in early infancy
by: Kazushige Ikeda, et al.
Published: (2022-07-01)

Preservative Sodium Benzoate as a Food Additive Alone and in Combination with Vitamin C and its Toxic Effects on the Liver and Kidney Function of Adult Male Rabbits
by: Shahid Jalil, et al.
Published: (2022-12-01)